C F Sier

Author PubWeight™ 17.83^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.	Blood	2000	1.69
2	Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.	Cancer Res	1994	1.18
3	Urokinase receptor and colorectal cancer survival.	Lancet	1994	1.18
4	Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage.	Brain	2001	1.10
5	Superoxide dismutases in relation to the overall survival of colorectal cancer patients.	Br J Cancer	1998	1.10
6	Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.	Cancer Res	2000	1.07
7	Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices.	Blood	2001	1.06
8	Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo.	FEBS Lett	2000	1.04
9	Expression of endoglin (CD105) in cervical cancer.	Br J Cancer	2009	1.01
10	Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.	Br J Cancer	1997	0.98
11	Prognostic value of the plasminogen activation system in patients with gastric carcinoma.	Cancer	1996	0.93
12	Glutathione S-transferase pi in colorectal tumors is predictive for overall survival.	Cancer Res	1995	0.88
13	PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor.	FEBS Lett	2001	0.87
14	Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.	Eur J Cancer	1995	0.81
15	Gastric mucosal plasminogen activators in Helicobacter pylori infection.	Dig Dis Sci	1996	0.80
16	Glutathione S-transferases in liver metastases of colorectal cancer. A comparison with normal liver and primary carcinomas.	Carcinogenesis	1994	0.79
17	MMP-9 activity in urine from patients with various tumors, as measured by a novel MMP activity assay using modified urokinase as a substrate.	Ann N Y Acad Sci	1999	0.78
18	Association of aneuploidy in index adenomas with metachronous colorectal adenoma development and a comparison.	Cancer	1992	0.75
19	Tetranectin expression in human colonic neoplasia.	Histopathology	1994	0.75